Dave Cantin



  • Automotive Mergers and Acquisitions
  • Automotive Industry Authority
  • Dealership Processes and Structure
  • Award-Winning Entrepreneur


  • Founder, DCG Giving
  • Long history of philanthropy in the pediatric cancer space
  • Serves on the board of Multiple Pediatric Cancer Organization
  • Forbes Council Member

Dave Cantin

The Founding of a Leading Organization

Dave Cantin founded the Dave Cantin Group (DCG) in 2017. Dave’s vision and experience were instrumental in forming one of the largest and most forward-thinking automotive M&A firms in the nation, and he brought on a world-class team of automotive authorities and M&A industry experts. 

Prior to DCG

Dave developed his renowned drive and dedication through various leadership roles within the automotive industry. Dave’s automotive experience spans over two decades, and his relentless passion, drive, and dedication to exploring innovative opportunities made him an industry authority and led to his closing of the second-largest automotive dealership transaction in US history – the sale of Prime Motor Group – consisting of more than 30 dealerships.

Relentless Dedication

Dave’s dedication to client legacies and foundational values of Respect, Relationship, Integrity, and Excellence are steadfast principles that have allowed DCG to achieve transactional revenues exceeding one billion dollars. 

Today, Dave spends his time engaged in philanthropic endeavors, providing thought leadership to various enterprises, and contributing his advisory services to DCG Brands.

Dedication to Philanthropy

Beyond his business achievements, Dave survived leukemia after five years of treatment and has made it his mission to harness the giving power of the automotive sector to eradicate childhood and adolescent cancer. His newly-formed nonprofit, DCG Giving, channels charitable contributions specifically aimed at research and development for treatments that can advance and save millions of young lives, letting adolescent cancer patients grow up into thriving adults. To date, Dave has assisted in raising more than $100 million for cancer research personally and through a percentage of the proceeds from every completed DCG transaction, going back to local communities where the transaction occurred.